Company / Cost of Revenue
UTAH MEDICAL PRODUCTS INC Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$20.2M
FY2025
5-year range
$16.6M / $20.2M
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 3 consecutive years, from $17M in FY2022 to $20M in FY2025.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of +5.2%.
Increased from $18M to $20M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- +5.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- UTAH MEDICAL PRODUCTS INC's cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +5.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 0.5% year-over-year.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.2M | +0.5% |
| FY2024 | $20.1M | +10.7% |
| FY2023 | $18.1M | +9.1% |
| FY2022 | $16.6M | -4.6% |
| FY2021 | $17.4M | +11.1% |
| FY2020 | $15.7M | +4.5% |
| FY2019 | $15.0M | -3.8% |
| FY2018 | $15.6M | -2.3% |
| FY2017 | $16.0M | -2.0% |
| FY2016 | $16.3M | +0.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026